HOME > Investors > Press Releases
Subject Announced interim unaudited results for the year ending December 31, 2006
Writer ViroMed
Date 2007/02/13

ViroMed Co., Ltd. (KOSDAQ: 084990) announced interim unaudited results for the year ending December 31, 2006.

Total revenue amounted to 3,868 million KRW, an increase of 86.9% from the previous year.

Operating loss for 2006 increased to 3,160 million KRW from 1,980 million KRW in 2005, which was mainly due to clinical trial costs and SG&A for the newly established sales department.

In summary, 2006 saw a net loss reduction of 5.6% (1,677 million KRW).